INDICATION AND EFFECT OF IMMUNOSUPPRESSION THERAPY IN SECONDARY GLAUCOMA PATIENTS WITH UVEITIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALI PANAHI R.; MORSALI S.M.; SAYAHMELI SIMA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Seminar Paper

Paper Information

Seminar: BIENNIAL CONGRESS ON IMMUNOLOGY, ASTHMA AND ALLERGY
Year:2007 | Issue:6

Download Full-Text

View:

197

Download:

Information Seminar Paper

Title

INDICATION AND EFFECT OF IMMUNOSUPPRESSION THERAPY IN SECONDARY GLAUCOMA PATIENTS WITH UVEITIS

Author(s)

ALI PANAHI R. | MORSALI S.M. | SAYAHMELI SIMA

Keywords

Not Registered.

Abstract

PURPOSE: To assess the Indication and effect of immunosuppression therapy in Secondary glaucoma patients.SETTING: Immunology and glaucoma Service, Department of Ophthalmology and Visual Sciences, Nickookary University Hospital.METHODS: All consecutive patients with glaucoma secondary to uveitis and inadequate intraocular pressure (IOP) control (IOP >21 mm Hg) under maximum-tolerated medical therapy had immunosuppression. Eleven patients with active uveitis were treated. The etiology of the uveitis was recorded. The ocular variables were IOP, best corrected visual acuity, number of antiglaucoma medications, and complications. Success was defined as an IOP between 6 mm Hg and 21 mm Hg (inclusive) without medication (complete success), or with 1 or more antiglaucoma The mean follow-up was 45.9 ± 11.6 months (range 23 to 56 months).RESULTS: immunosuppression therapy significantly reduced IOP from a mean baseline value of 35.1±7.0 mm Hg (range 23 to 48 mm Hg) to a mean final value of 18.1±4.9 mm Hg (range 12 to 30 mm Hg) (P<.0001). Complete success was achieved in 6 eyes (54.5%) and qualified success, in 10 eyes (90.9%). The mean number of pretreatment and final antiglaucoma medications was 3.4±0.8 (range 2 to 4) and 0.7±1.2 (range 0 to 3), respectively (P =.0004). Complications were minor and included transient hyphema and postoperative IOP spike.CONCLUSION: This preliminary study suggests that immunosuppressant therapy is a safe, effective surgical alternative for treating glaucoma in patients with uveitis.

Cites

No record.

References

No record.

Cite

APA: Copy

ALI PANAHI, R., MORSALI, S.M., & SAYAHMELI, SIMA. (2007). INDICATION AND EFFECT OF IMMUNOSUPPRESSION THERAPY IN SECONDARY GLAUCOMA PATIENTS WITH UVEITIS. BIENNIAL CONGRESS ON IMMUNOLOGY, ASTHMA AND ALLERGY. SID. https://sid.ir/paper/902537/en

Vancouver: Copy

ALI PANAHI R., MORSALI S.M., SAYAHMELI SIMA. INDICATION AND EFFECT OF IMMUNOSUPPRESSION THERAPY IN SECONDARY GLAUCOMA PATIENTS WITH UVEITIS. 2007. Available from: https://sid.ir/paper/902537/en

IEEE: Copy

R. ALI PANAHI, S.M. MORSALI, and SIMA SAYAHMELI, “INDICATION AND EFFECT OF IMMUNOSUPPRESSION THERAPY IN SECONDARY GLAUCOMA PATIENTS WITH UVEITIS,” presented at the BIENNIAL CONGRESS ON IMMUNOLOGY, ASTHMA AND ALLERGY. 2007, [Online]. Available: https://sid.ir/paper/902537/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops